JOHN PETER MCLAUGHLIN
CIK 1277967 · CEO · last filed 2023-05-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$397.7K
Companies
6
Total Filings
43
Lifetime Open-Market Net
-$855.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNSR | Director | 53,631 | $5.82 | $312.1K | $0 | 5 | 2023-05-30 |
| RMTI | Director | 136,974 | $0.62 | $85.6K | $0 | 4 | 2021-06-22 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | CEO | 477,934 | — | — | -$855.8K | 18 | 2020-12-22 |
| Seagen Inc. (SGEN) Delisted | Director | 39,400 | $228.74 | $9.01M | $0 | 10 | 2016-05-24 |
| Adverum Biotechnologies, Inc. (AAVL) Delisted | Director | 23,613 | — | — | $0 | 4 | 2016-02-17 |
| ANESIVA, INC. (ANSV) Delisted | Chief Executive Officer | 118,826 | — | — | $0 | 2 | 2008-02-08 |
Recent Filings · Page 4 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-09-13 | Seagen Inc. (SGEN) Delisted | Exer (M) | +25,000 | $245.5K | EDGAR |
| 2011-05-25 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +30,501 | $0 | EDGAR |
| 2011-05-24 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-25 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-09-16 | PDL BIOPHARMA, INC. (PDLI) Delisted | Exer (M) | +28,415 | $153.8K | EDGAR |
| 2009-05-19 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-06 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +47,916 | $0 | EDGAR |
| 2008-10-10 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-20 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.